Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease

Journal of Neurology

Volumn 257, Issue 1, 2010, Pages 139-141

  Santamato, Andrea ^a   Ranieri, Maurizio ^b   Panza, Francesco ^b   Zoccolella, Stefano ^a   Frisardi, Vincenza ^b   Solfrizzi, Vincenzo ^b   Amoruso, Maria Teresa ^a   Amoruso, Loredana ^a   Fiore, Pietro ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; DECARBOXYLASE INHIBITOR; LEVODOPA; SERTRALINE;

AGED; CASE REPORT; CONTROLLED DRUG RELEASE; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSTONIA; ELECTROMYOGRAPHY; GAIT DISORDER; HUMAN; LETTER; LOW BACK PAIN; MALE; PAIN ASSESSMENT; PARKINSON DISEASE; PILATES; PISA SYNDROME; PRIORITY JOURNAL; STRETCHING EXERCISE;

AGED; BOTULINUM TOXIN TYPE A; DYSTONIA; EXERCISE THERAPY; HUMANS; MALE; NEUROMUSCULAR AGENTS; PARKINSON DISEASE; POSTURE; SYNDROME; TREATMENT OUTCOME;

EID: 74849124588     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5310-4     Document Type: Letter

References (14)

1. F Yokochi 2006 Lateral flexion in Parkinson's disease and Pisa syndrome J Neurol 253 Suppl 7 vii17 vii20 10.1007/s00415-006-7005-4 17131222 (Pubitemid 44833065)
2. P Solla A Cannas P Tacconi MG Marrosu 2008 Lateral trunk flexion and Pisa syndrome in Parkinson's disease. Are they really always different conditions although denoting similar features? J Neurol 255 3 450 451 10.1007/s00415-008- 0688-y 18297330
3. K Ekbom Lindholm L Ljundberg 1972 New dystonic syndrome associated with butyrophenone therapy Z Neurol 202 94 103 10.1007/BF00316159 1:STN:280:DyaE3s%2FgtV2qsw%3D%3D 4115928
4. T Suzuki H Matsuzaka 2002 Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management CNS Drugs 16 3 165 174 10.2165/00023210-200216030- 00003 1:CAS:528:DC%2BD38Xjtleiurg%3D 11888337
5. A Villarejo A Camacho R García-Ramos, et al. 2003 Cholinergic-dopaminergic imbalance in Pisa syndrome Clin Neuropharmacol 26 119 121 10.1097/00002826-200305000-00004 12782913 (Pubitemid 36676289)
6. YT Kwak IW Han J Baik, et al. 2000 Relation between cholinesterase inhibitor and Pisa syndrome Lancet 355 9222 2222 10.1016/S0140-6736(00)02412-0 1:STN:280:DC%2BD3czjslOmsg%3D%3D 10881902
7. G Cossu M Melis G Melis, et al. 2004 Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report Mov Disord 19 10 1243 1244 10.1002/mds.20164 15389998 (Pubitemid 39429972)
8. P Solla A Cannas S Congia, et al. 2008 Levodopa/carbidopa/entacapone- induced acute Pisa syndrome in a Parkinson's disease patient J Neurol Sci 275 1-2 154 156 10.1016/j.jns.2008.07.017 1:CAS:528:DC%2BD1cXhtlyiu7zI 18814889
9. DJ Gelb E Oliver S Gilman 1999 Diagnostic criteria for Parkinson disease Arch Neurol 56 1 33 39 10.1001/archneur.56.1.33 1:STN:280:DyaK1M7itVKgtg%3D%3D 9923759 (Pubitemid 29046907)
10. Fahn S (1989) Assessment of the primary dystonias. In: Munsat TL (ed) Quantification of neurologic deficit. Butterworths, Boston, pp 241-270
11. DD Price FM Bush S Long SW Harkins 1994 A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales Pain 56 2 217 226 10.1016/0304-3959(94)90097-3 1:STN:280:DyaK2c3nslKjtw%3D%3D 8008411 (Pubitemid 24067851)
12. R Benecke D Dressler 2007 Botulinum toxin treatment of axial and cervical dystonia Disabil Rehabil 29 23 1769 1777 10.1080/01421590701568262 18033602 (Pubitemid 350176808)
13. CL Comella KM Shannon J Jaglin 1998 Extensor truncal dystonia: successful treatment with botulinum toxin injections Mov Disord 13 3 552 555 10.1002/mds.870130330 1:STN:280:DyaK1c3ntlyjuw%3D%3D 9613753 (Pubitemid 28221514)
14. L Bonanni A Thomas S Varanese V Scorrano M Onofrj 2007 Botulinum toxin treatment of lateral axial dystonia in Parkinsonism Mov Disord 22 14 2097 2103 10.1002/mds.21694 17685467